IPO Year:
Exchange: NASDAQ
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 5/21/2025 | Outperform | William Blair | |
| 9/5/2024 | $8.00 | Buy | Craig Hallum |
| 8/28/2024 | Outperform → Mkt Perform | Barrington Research | |
| 3/20/2023 | $11.00 → $2.00 | Overweight → Equal-Weight | Stephens |
William Blair initiated coverage of Lifecore Biomedical with a rating of Outperform
Craig Hallum initiated coverage of Lifecore Biomedical with a rating of Buy and set a new price target of $8.00
Barrington Research downgraded Lifecore Biomedical from Outperform to Mkt Perform
Stephens downgraded Lifecore Biomedical from Overweight to Equal-Weight and set a new price target of $2.00 from $11.00 previously